Scientists have discovered a never-before-seen antibiotic that shows promising in treating drug-resistant infections.

Phages are particularly advantageous anti-infectives as they are novel therapeutics, can target antibiotic-resistant bacteria ...

Empiric concomitant coverage of MRSA and multidrug-resistant organisms is not necessary for most patients with sepsis.

Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a ...

Explore the list of 280 hospitals with the lowest MRSA rates based on CMS data from October 2023 to September 2024.

During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH , investigator at The Lundquist Institute for Biomedical Innovation at ...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...

US clinical stage biotech Armata Pharmaceuticals’ investigational phage therapy, AP-SA02, demonstrated earlier resolution in ...

Revium Rx (formerly Revium Recovery Inc. (OTC: RVRC), a biopharmaceutical company developing advanced lipid-based therapeutics for infectious and oncologic diseases, today announced significant ...

Illness severity, advanced age, and chronic liver disease were strong predictors of 30-day mortality among hospitalized patients with CAP.

ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School ...

Staphylococcus aureus is a gram-positive bacterium that is ubiquitous on human skin and normally does not cause problems, but when it enters the body, it can cause serious infections. The growing ...